Katelyn S. Johnson
Identifying Strategic Opportunities.
With a breadth of experience advising and scaling early-stage B2B SaaS companies, Katelyn’s focus at Safeguard includes identifying strategic investment opportunities and realizing potential within current partner companies.
Adding to Safeguard’s depth and expertise in healthcare, financial services and digital media, Katelyn has a proven track record in both venture capital and medical device manufacturing.
Before joining Safeguard, Katelyn worked as an associate at Boston-based Sigma Prime Ventures, offering tactical expertise to a portfolio of technology-enabled service companies. While mentoring at MIT, Harvard Business School, TechStars and MassChallenge, she became familiar with the local tech community, which enabled her to source deals for the firm. Katelyn sits on the New England Venture Capital Association’s board of advisors subcommittee focused on supporting the growth and development of venture investors.
Between 2013 and 2015, Katelyn earned an M.B.A. at Harvard Business School. During this time, she also interned at several high-profile organizations, including Schooner Capital, TSG Consumer Partners, and Fortune 500 Company General Mills.
At W.L. Gore & Associates, she served as project manager and oversaw product commercialization for new and existing products in the Gore-Tex Medical Products Division, specifically cardiovascular stents and grafts.
Katelyn received a B.S. in mechanical engineering at the University of Delaware.
"Building interpersonal relationships, networking and managing teams is an essential part of a start-up company's growth and development. I’m thrilled to be part of a team that has been fostering innovation for decades and building an ecosystem of strategic partnerships and connections for entrepreneurs to leverage and scale their businesses."
March 7, 2017
This post originally appeared on CIOReview.com on March 6th, 2017. By: Peter Coffee, VP for Strategic Research, Salesforce and Scott Snyder, Chief Technology and Innovation Officer,…
February 7, 2017
Nearly 60 percent of all U.S. venture capital activity is concentrated in the Bay Area, Boston metro, and New York City’s orbit. For some entrepreneurs,…
January 26, 2017
Over the last 18 months, an alarming number of medical device companies’ challenges with data security have been exposed. In 2015, Hospira’s LifeCare PCA3 and…